PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Alacris Theranostics GmbH, Berlin, Germany. lehrach@molgen.mpg.de.\', \'Max Planck Institute for Molecular Genetics, Ihnestraße 63, 14195, Berlin, Germany. lehrach@molgen.mpg.de.\', \'Alacris Theranostics GmbH, Berlin, Germany.\', \'State Sanitary Directorate, City Government, Vienna, Austria.\', \'Department of Medicine I, Division of Infectious Diseases, Medical University of Vienna, Vienna, Austria.\', \'LEAD Horizon, Vienna, Austria.\', \'University of Wuppertal, Wuppertal, Germany.\', \'University of Bonn, Bonn, Germany.\', \'University of Frankfurt, Frankfurt, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41598-022-08934-2
?:doi
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 35379812
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
?:title
  • Proposal of a population wide genome-based testing for Covid-19.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all